NASDAQ : DMAA
Drugs Made In America Acquisition Corp. — Key statistics
Financials · Shell Companies · United States
Last price 10.89 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 264.38M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 264.38M |
| Enterprise Value | 264.71M |
Dates
| Measure | Value |
|---|
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 24.28M |
| Shares Outstanding | 24.28M |
| Shares Change (YoY) | +285.00% |
| Shares Change (QoQ) | -8.61% |
| Owned by Insiders (%) | 1.24% |
| Owned by Institutions (%) | 55.37% |
| Float | 19.79M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 58.96 |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 43.43 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.02 |
| Quick Ratio | 0.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -1.83% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | n/a |
| 52-Week Price Change | +5.63% |
| 50-Day Moving Average | 10.82 |
| 200-Day Moving Average | 10.59 |
| Relative Strength Index (RSI) | 66.97 |
| Average Volume (20 Days) | 15,804 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 89,088 |
| Short Previous Month | 89,787 |
| Short % of Shares Out | 0.37% |
| Short % of Float | 0.45% |
| Short Ratio (days to cover) | 15.50 |
Incomestatement
| Measure | Value |
|---|
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -2.63M |
| Pretax Income | 6.09M |
| Net Income | 6.09M |
| EBITDA | n/a |
| EBIT | -2.63M |
| Earnings Per Share (EPS) | $0.18 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 20,280 |
| Total Debt | 350,000 |
| Net Cash | -329,720 |
| Net Cash Per Share | -$0.01 |
| Equity (Book Value) | -7.41M |
| Book Value Per Share | -0.31 |
| Working Capital | -2.88M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -517,145 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | -98.96M |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Measure | Value |
|---|
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -285.00% |
| Shareholder Yield | -285.00% |
| Earnings Yield | 1.70% |
| FCF Yield | n/a |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |